Anti-C1QA functional antibody

Anti-C1QA functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to C1QA/C1QA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0706-Ab-1/ GM-Tg-hg-SE0706-Ab-2Anti-Human C1QA monoclonal antibodyHuman
GM-Tg-rg-SE0706-Ab-1/ GM-Tg-rg-SE0706-Ab-2Anti-Rat C1QA monoclonal antibodyRat
GM-Tg-mg-SE0706-Ab-1/ GM-Tg-mg-SE0706-Ab-2Anti-Mouse C1QA monoclonal antibodyMouse
GM-Tg-cynog-SE0706-Ab-1/ GM-Tg-cynog-SE0706-Ab-2Anti-Cynomolgus/ Rhesus macaque C1QA monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0706-Ab-1/ GM-Tg-felg-SE0706-Ab-2Anti-Feline C1QA monoclonal antibodyFeline
GM-Tg-cang-SE0706-Ab-1/ GM-Tg-cang-SE0706-Ab-2Anti-Canine C1QA monoclonal antibodyCanine
GM-Tg-bovg-SE0706-Ab-1/ GM-Tg-bovg-SE0706-Ab-2Anti-Bovine C1QA monoclonal antibodyBovine
GM-Tg-equg-SE0706-Ab-1/ GM-Tg-equg-SE0706-Ab-2Anti-Equine C1QA monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0706-Ab-1/ GM-Tg-hg-SE0706-Ab-2; GM-Tg-rg-SE0706-Ab-1/ GM-Tg-rg-SE0706-Ab-2;
GM-Tg-mg-SE0706-Ab-1/ GM-Tg-mg-SE0706-Ab-2; GM-Tg-cynog-SE0706-Ab-1/ GM-Tg-cynog-SE0706-Ab-2;
GM-Tg-felg-SE0706-Ab-1/ GM-Tg-felg-SE0706-Ab-2; GM-Tg-cang-SE0706-Ab-1/ GM-Tg-cang-SE0706-Ab-2;
GM-Tg-bovg-SE0706-Ab-1/ GM-Tg-bovg-SE0706-Ab-2; GM-Tg-equg-SE0706-Ab-1/ GM-Tg-equg-SE0706-Ab-2
Products NameAnti-C1QA monoclonal antibody
Formatmab
Target NameC1QA
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-C1QA benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0706-Ag-1Recombinant multi-species C1QA protein
    ORF Viral VectorpGMLP002262human C1QA Lentivirus plasmid
    ORF Viral VectorvGMLP002262human C1QA Lentivirus particle
    ORF Viral VectorpGMLPm002257mouse C1qa Lentivirus plasmid
    ORF Viral VectorvGMLPm002257mouse C1qa Lentivirus particle


    Target information

    Target IDGM-SE0706
    Target NameC1QA
    Gene ID712,12259,298566,708477,478194,101096082,534961,100058097
    Gene Symbol and SynonymsAdic,C1q,C1QA,C1QD1
    Uniprot AccessionP02745,P31720,Q5E9E3
    Uniprot Entry NameC1QA_HUMAN,C1QA_RAT,C1QA_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000173372
    Target ClassificationN/A

    The target: C1QA, gene name: C1QA, also named as . This gene encodes the A-chain polypeptide of serum complement subcomponent C1q, which associates with C1r and C1s to yield the first component of the serum complement system. C1q deficiency is associated with lupus erythematosus and glomerulonephritis. C1q is composed of 18 polypeptide chains which include 6 A-chains, 6 B-chains, and 6 C-chains. Each chain contains an N-terminal collagen-like region and a C-terminal C1q globular domain. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.